Percentage of patients aged 20 years and older with risk factors for coronary artery disease who have an elevated LDL-C and who are taking a lipid lowering agent or have initiated therapeutic lifestyle changes
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting
-
1.14 Numerator
Patients who are taking lipid lowering therapy or who have initiated therapeutic lifestyle changes.
-
1.15 Denominator
Patients aged 20 and older with risk factors for coronary artery disease who had an elevated LDL-C in the past 12 months.
-
Exclusions
SPECIFIC EXCLUSIONS:
• Presence of TSH Labs Result Value > 10 In the past 6 Months
• Presence of NEPHROTIC SYNDROME in past 12 months
• CAD Validation is confirmed
• Diabetes Validation is confirmed
• PAD Validation is confirmed
• AAA in the past
• Carotid endarterectomy in the past
GENERAL EXCLUSIONS:
• Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
• Patients who have been in a skilled nursing facility in the last 3 months
• Patient or provider feedback indicating allergy, intolerance or contraindication to the drug in the past
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative DataInitial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-